Diego Reynoso named Ingredion EVP & CFO as Jason Payant returns to VP Finance role
Ingredion has appointed Diego Reynoso as Executive Vice President and Chief Financial Officer, effective October 1, 2026. Current Interim CFO Jason Payant will return to his role as Vice President, Finance, Global Texture & Healthful Solutions on the same date. Reynoso, 51, brings extensive CFO experience from companies like The Boston Beer Company and Tyson Foods.
Ingredion Market Sentiment
This article analyzes the market sentiment for Ingredion (INGR) based on analyst consensus, short interest, options flow, and insider activity. Key signals show an "Equal-Weight" analyst consensus, rising short interest, bearish options flow, and net selling by insiders over the past 30 days. The average analyst price target for INGR is $129, indicating a potential upside of 20.9%.
Ingredion appoints Diego Reynoso as CFO effective Oct. 1 By Investing.com
Ingredion Incorporated announced the appointment of Diego Reynoso as Chief Financial Officer, effective October 1, 2026. Reynoso will be responsible for leading the finance organization, contributing to the company's growth strategy, and overseeing enterprise productivity and capital allocation. He brings extensive experience from previous roles at Boston Beer Company, Tyson Foods, and other major food and beverage companies.
Diego Reynoso to join Ingredion as Chief Financial Officer
Ingredion Incorporated announced the appointment of Diego Reynoso as Chief Financial Officer, effective October 1, 2026. Reynoso, formerly CFO at Boston Beer Company, will be a key part of the executive leadership team, focusing on Ingredion's growth strategy, capital allocation, and integration execution. His extensive experience in the food and beverage industry is expected to drive profitable growth and shareholder value.
Ingredion Appoints Diego Reynoso as Executive Vice President and CFO Effective October 2026
Ingredion Incorporated announced the appointment of Diego Reynoso as Executive Vice President and Chief Financial Officer, effective October 1, 2026. Reynoso, previously CFO at The Boston Beer Company, will receive an annual base salary of $725,000, a sign-on cash award of $770,000, and equity grants. Jason Payant, the interim CFO, will transition to a different finance role within the company.
Equity Investment Corp Acquires New Shares in Ingredion Incorporated $INGR
Equity Investment Corp recently acquired a new position in Ingredion Incorporated, purchasing 871,065 shares valued at approximately $82.5 million, making them own 1.38% of the company. Other institutional investors like BlackRock Inc. and First Trust Advisors LP also adjusted their holdings. The article also notes recent insider selling by a director and provides an overview of analyst ratings and Ingredion's financial performance.
Foster & Motley Inc. Purchases Shares of 33,882 Ingredion Incorporated $INGR
Foster & Motley Inc. has acquired a new stake of 33,882 shares in Ingredion Incorporated (NYSE:INGR), valued at approximately $3.21 million. This makes Foster & Motley Inc. the latest institutional investor to report a position in Ingredion, which has also seen director David B. Fischer sell a portion of his holdings. Ingredion recently reported earnings exceeding consensus estimates and has received varied analyst ratings, with a current average "Hold" rating and a consensus price target of $121.29.
Alpine Woods Capital Investors LLC Purchases New Shares in Ingredion Incorporated $INGR
Alpine Woods Capital Investors LLC acquired 9,622 shares of Ingredion Incorporated (NYSE:INGR), valued at approximately $911,000, as part of a new position in Q2. Other institutional investors also adjusted their holdings, with institutional ownership now at 85.27%. Ingredion reported strong Q2 earnings, beating analyst estimates for EPS and revenue, and maintained its fiscal 2026 EPS guidance.
UNIVEST FINANCIAL Corp Takes $1.31 Million Position in Ingredion Incorporated $INGR
UNIVEST FINANCIAL Corp has acquired a new position of 13,879 shares in Ingredion Incorporated, valued at approximately $1.31 million, during the second quarter. Other institutional investors have also adjusted their holdings in Ingredion, which collectively owns 85.27% of the company's stock. Ingredion recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend, while analysts maintain a consensus "Hold" rating with an average price target of $121.29.
Ingredion (NYSE: INGR) exec adds to phantom stock stake
David Eric Seip, SVP, Global Ops and CSCO at Ingredion Inc (NYSE: INGR), was granted 16.6010 units of phantom stock on August 14, 2026. These units, allocated under a Non-Qualified Deferred Compensation Plan, are based on a reference price of $105.20 per share. Following this transaction, Seip's total holdings in phantom stock units increased to 13,394.4941, each representing the right to receive one share of common stock.
Ingredion (NYSE: INGR) SVP adds deferred phantom stock units
Ingredion Inc. SVP, CIO & Head of Protein Fortification, Michael J. Leonard, acquired 32.470 phantom stock units on August 14, 2026, under a Non-Qualified Deferred Compensation Plan. This transaction increases his total phantom stock holdings to 1,833.948 units, with each unit representing the right to receive one share of common stock. The units were valued based on Ingredion's closing stock price of $105.20 on the allocation date.
Ingredion Incorporated (NYSE:INGR) Receives Average Rating of "Hold" from Analysts
Ingredion Incorporated (NYSE:INGR) has received an average "Hold" rating from analysts, with eight out of nine brokerages recommending a hold and one a buy. The average 12-month price target is $121.29, above its opening price of $105.14. The company recently exceeded quarterly earnings expectations, reporting $2.82 EPS against an estimated $2.71, and declared a quarterly dividend of $0.82 per share, representing a 3.1% yield.
Ingredion | 8-K: INGREDION INCORPORATED REPORTS SECOND QUARTER 2026 RESULTS
This document is an 8-K filing by Ingredion Incorporated, reporting its second quarter 2026 results. The filing is a standard regulatory disclosure for public companies.
5 Revealing Analyst Questions From Ingredion’s Q2 Earnings Call
Ingredion's Q2 earnings exceeded analyst expectations with strong revenue and adjusted EPS, driven by its Texture & Healthful Solutions segment. Despite operational challenges at its Argo facility and softer demand in some areas, the company's management addressed analyst concerns regarding guidance, sustainability of improvements, and integration of Tate & Lyle. Upcoming quarters will focus on margin recovery, input cost pass-through, and regulatory milestones for the Tate & Lyle acquisition.
5 Revealing Analyst Questions From Ingredion’s Q2 Earnings Call
Ingredion's Q2 results exceeded analyst expectations in revenue and adjusted EPS, driven by its Texture & Healthful Solutions segment, despite challenges at the Argo facility. Analysts questioned management on U.S./Canada guidance assumptions, Argo's margin improvements, volume softness, the Tate & Lyle integration, and the financial impact of Argo's issues. The company addressed these concerns, noting operational improvements and expected normalization.
Bank of America Corp DE Acquires 47,057 Shares of Ingredion Incorporated $INGR
Bank of America Corp DE increased its stake in Ingredion Incorporated by 10.3% in the first quarter, acquiring an additional 47,057 shares, bringing its total to 501,948 shares valued at $56.5 million. Despite institutional investors owning 85.27% of the company, analyst sentiment remains cautious with a consensus "Hold" rating and a target price of $121.29. Ingredion recently exceeded earnings expectations with $2.82 EPS and $1.85 billion in revenue, maintaining its 2026 EPS guidance and offering a 3.1% dividend yield.
Q2 Earnings Roundup: Ingredion (NYSE:INGR) And The Rest Of The Ingredients, Flavors & Fragrances Segment
This article provides a Q2 earnings roundup for companies in the ingredients, flavors & fragrances segment, focusing on Ingredion (NYSE:INGR) and its peers. It details individual company performances, highlighting revenue and EPS against analyst expectations, and discusses general tailwinds and headwinds affecting the industry. The report covers Ingredion, Archer-Daniels-Midland, International Flavors & Fragrances, Bunge Global, and Darling Ingredients, noting their stock performance post-earnings.
Pacer Advisors Inc. Has $825,000 Position in Ingredion Incorporated $INGR
Pacer Advisors Inc. significantly reduced its stake in Ingredion Incorporated ($INGR) by 96.3% in the first quarter, selling 189,573 shares and retaining 7,319 shares valued at $825,000. Despite this, Ingredion exceeded quarterly earnings expectations, reporting $2.82 EPS against a $2.71 consensus and maintaining its fiscal 2026 EPS guidance. Institutional investors collectively own 85.27% of the company, which also pays a quarterly dividend of $0.82 per share, yielding 3.1%.
Royal Bank of Canada Purchases 11,652 Shares of Ingredion Incorporated $INGR
Royal Bank of Canada increased its stake in Ingredion Incorporated by 12.1% in the first quarter, purchasing an additional 11,652 shares to reach a total of 108,009 shares valued at $12.2 million. Ingredion reported strong quarterly earnings, exceeding analyst expectations for EPS and revenue, and reaffirmed its fiscal 2026 EPS guidance. Despite a "Hold" consensus rating from analysts, institutional investors collectively own a significant 85.27% of the company's stock.
Ingredion Incorporated (INGR) stock price, news, quote and history
This article provides a comprehensive overview of Ingredion Incorporated (INGR) stock, including its current price, market performance, key financial metrics, and company profile. It also features analyst insights, recent news, and comparison data with similar companies in the packaged foods industry.
Ingredion Incorporated (INGR) stock price, news, quote and history
This Yahoo Finance page provides comprehensive information on Ingredion Incorporated (INGR), a company specializing in sweeteners, starches, and nutrition ingredients. The article includes current stock price, historical data, performance overview, earnings trends, analyst insights, and financial highlights such as market cap, P/E ratio, and profitability metrics. It also offers tools to compare INGR with similar companies in the Packaged Foods industry.
Ingredion Inc Q2 2026: Revenue $1.85B, EPS $1.78— 10-Q Summary
Ingredion Inc reported its second-quarter 2026 results, with revenue at $1.85 billion, up 1% year-over-year, while net income and diluted EPS significantly declined by 42% and 40.5% respectively, due to higher manufacturing costs and operational disruptions. The company also announced a pending acquisition of Tate & Lyle to expand its specialty ingredients portfolio and sold a majority stake in its Pakistan business.
Ingredion (INGR) Director David Fischer Sells 1,662 Shares
Ingredion (INGR) Director David Fischer sold 1,662 shares of the company's stock for approximately $170,039, bringing his total direct ownership to 19,929.8698 shares. This sale contributes to a bearish insider sentiment, with no insider buys and 11 insider sells over the past year. Despite insider selling, the stock is considered modestly undervalued by GuruFocus's model, with a GF Value of $114.39 against a trading price of $102.31, and institutions show continued interest with more gurus adding to their positions than trimming.
Is Ingredion (INGR) Fully Valued After Reaffirming 2026 Guidance?
Ingredion (INGR) has reaffirmed its 2026 earnings guidance and announced modest net sales growth expectations for Q3, alongside Q2 results, a completed share buyback, and progress on the Tate & Lyle acquisition. While the company's share price has seen recent gains, its year-to-date and one-year returns are down, suggesting fading momentum. Analysts are debating its valuation, with one narrative suggesting it's 18.2% overvalued at $88.23 compared to its current price of $104.33, primarily due to the potential for the Tate & Lyle deal to transform Ingredion into a higher-margin specialty ingredients platform.
Ingredion director David Fischer sells $170,039 in company stock
Ingredion director David B. Fischer sold 1,662 shares of company stock for $170,039 on August 5, 2026, with shares trading at a weighted average price of $102.31. Following the sale, Fischer directly owns 19,929.8698 shares, and the company maintains a dividend yield of 3.18% with 29 years of consecutive dividend payments. This transaction follows Ingredion's second-quarter 2026 results, which surpassed Wall Street expectations for both adjusted earnings and revenue.
Ingredion (NYSE:INGR) Director David Fischer Sells 1,662 Shares
Ingredion (NYSE:INGR) Director David Fischer sold 1,662 shares of the company's stock for approximately $170,039, reducing his direct holdings by 7.7% to 19,930 shares. The company recently reported strong quarterly earnings, beating estimates with $2.82 EPS and 0.9% revenue growth, while maintaining its fiscal 2026 EPS guidance. Ingredion also declared a quarterly dividend of $0.82 per share, representing a 3.2% yield.
Ingredion (NYSE: INGR) director David Fischer sells 1,662 shares
Ingredion Inc. director David B. Fischer sold 1,662 shares of common stock on August 5, 2026, at a weighted average price of $102.31 per share. The transaction occurred in multiple trades ranging from $102.13 to $102.55, and after the sale, Fischer directly owns 19,929.8698 shares, including restricted stock units (RSUs). This insider transaction is categorized with a moderate impact and negative sentiment.
Ingredion director David Fischer sells $170,039 in company stock
Ingredion Inc director David Fischer sold 1,662 shares of company stock for a total of $170,039 on August 5, 2026. This transaction leaves him with 19,929.8698 shares in direct beneficial ownership. The sale occurred shortly after Ingredion reported strong Q2 2026 financial results, exceeding Wall Street expectations for both earnings and revenue.
Analysts Offer Insights on Consumer Goods Companies: Ingredion (INGR), Coca-Cola Europacific Partners (CCEP) and The Hershey Company (HSY)
Analysts have provided insights into several consumer goods companies, including Ingredion (INGR), Coca-Cola Europacific Partners (CCEP), and The Hershey Company (HSY). BMO Capital maintained a Hold rating on Ingredion, while Jefferies upheld a Buy rating for Coca-Cola Europacific Partners. J.P. Morgan maintained a Hold rating for The Hershey Company, with varying price targets and consensus ratings across the board.
Ingredion's Acquisition of Tate & Lyle Should Accelerate Specialty Ingredients Growth
This article discusses Ingredion's acquisition of Tate & Lyle, expecting it to boost the company's growth in specialty ingredients. It also outlines Ingredion's business strategy, which involves manufacturing starches and sweeteners from corn and other raw materials for use primarily in food and beverages. The report further notes that Ingredion's shares rose as a US plant returned to normal production.
Ingredion Inc SEC Filing (Aug 5, 2026)
This article details an SEC Form 144 filing by Ingredion Inc (INGR) on August 5, 2026. The filing indicates a proposed sale of 1662 shares of common stock by an individual, acquired through stock awards from the issuer on May 15, 2013, with an aggregate market value of $170,034.00, to be executed via Stifel Nicolaus & Company Inc on the NYSE. The document provides details about the securities to be sold and certifies no knowledge of material adverse information not publicly disclosed.
Ingredion (NYSE:INGR) Given New $108.00 Price Target at UBS Group
UBS Group has raised its price target for Ingredion (NYSE:INGR) to $108.00 from $104.00, while maintaining a "neutral" rating. This new target suggests a potential upside of 4.52% from the stock's previous close. The adjustment follows Ingredion's recent quarterly earnings beat, where it surpassed analyst expectations for both adjusted EPS and revenue.
Ingredion Inc (INGR) (Q2 2026) Earnings Call Highlights: Strategic Growth Amid Operational Headwinds
Ingredion Inc (INGR) reported Q2 2026 net sales of $1.85 billion, up 1% year-over-year, despite a 5% decline in adjusted operating income. The Texture and Healthful Solutions segment performed strongly, achieving its second-highest quarterly operating income ever, while the Food and Industrial Ingredients US/Canada segment faced challenges due to production issues at the Argo facility and softer demand. The company reaffirmed its full-year 2026 adjusted EPS guidance and is proceeding with the acquisition of Tate & Lyle, which is expected to drive significant accretion and synergies.
UBS Adjusts Price Target on Ingredion to $108 From $104, Maintains Neutral Rating
UBS has raised its price target for Ingredion (NYSE: INGR) to $108 from $104, while maintaining a Neutral rating on the stock. This adjustment follows recent company news, including Ingredion's reaffirmed full-year 2026 earnings guidance and its second-quarter 2026 financial results.
Amundi Boosts Stake in Ingredion Incorporated $INGR
Amundi increased its stake in Ingredion Incorporated by 19.4% in Q1 2026, bringing its holdings to 142,282 shares valued at approximately $16 million. This comes as Ingredion reported strong Q2 results, exceeding EPS and revenue expectations, and reaffirmed its 2026 adjusted EPS guidance while anticipating significant synergies from its Tate & Lyle acquisition. Despite positive news, analysts maintain a cautious "Hold" rating on the stock.
Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
Ingredion (INGR) reported better-than-expected Q2 2026 earnings, with adjusted earnings of $2.82 per share and net sales of $1,850 million, surpassing analyst estimates. This performance was driven by strong growth in Texture & Healthful Solutions, favorable currency impacts, and improved Protein Fortification results, despite production issues at its Argo facility and macroeconomic pressures in Mexico. The company reaffirmed its full-year adjusted earnings guidance of $10.30-$10.90 per share, anticipating continued growth in Texture & Healthful Solutions but a decline in U.S./Canada operating income due to past Argo-related headwinds.
Ingredion Q2 Earnings Call Highlights
Ingredion (NYSE:INGR) reported Q2 2026 results that met expectations, with net sales up 1% to $1.85 billion and adjusted operating income down 5% due to Argo production issues and softer demand. The Texture & Healthful Solutions segment continued to drive growth, while the company reaffirmed its full-year adjusted EPS outlook despite rising tapioca costs and the sale of its Pakistan business. The proposed acquisition of Tate & Lyle was approved by shareholders and awaits regulatory review.
Ingredion Inc (NYSE: INGR) SVP receives new phantom stock award
Ingredion Inc's SVP, CIO & Head of Protein Fortification, Michael J. Leonard, was granted 34.343 phantom stock units on July 31, 2026, under the company's Non-Qualified Deferred Compensation Plan. The units were valued at $99.462 per share, and this allocation brings his total phantom stock holdings to 1,801.478 units, including those from dividend reinvestment. Each unit represents the right to receive one share of common stock.
Ingredion Inc (NYSE: INGR) SVP boosts phantom stock holdings in deferred plan
Ingredion Inc.'s SVP, Global Operations and CSCO, David Eric Seip, reported an acquisition of 17.5600 phantom stock units on July 31, 2026. This derivative award was granted under the company's Non-Qualified Deferred Compensation Plan, valued at the closing share price of $99.458. Following this transaction, Seip now holds a total of 13,377.8931 phantom stock units, which include units accumulated through dividend reinvestment.
Earnings call transcript: Ingredion tops Q2 2026 estimates as Argo stabilizes
Ingredion reported Q2 2026 adjusted EPS of $2.82 and revenue of $1.85 billion, exceeding analyst estimates, primarily driven by strong performance in its Texture & Healthful Solutions segment and the stabilization of its Argo plant operations. Despite continued margin pressure and macroeconomic headwinds in Mexico, the company reaffirmed its full-year adjusted EPS guidance. Ingredion is also progressing with its acquisition of Tate & Lyle, which is expected to transform its business towards higher-value solutions.
Ingredion: Better-for-you foods hinge on texture as much as nutrition
Ingredion emphasizes that while healthy eating drives the demand for better-for-you foods, texture and taste are crucial for consumer engagement. The company showcased its ingredient solutions at IFT FIRST, demonstrating how to reduce sugar and increase protein/fiber without sacrificing sensory experience, and launched an AI-powered tool called Ask Ingredion to assist CPG companies with formulation decisions. Ingredion believes that texture, often a complex and dynamic perception, must be considered early in the product development process for successful better-for-you food formulations.
Ingredion’s (NYSE:INGR) Q2 CY2026 Sales Top Estimates
Ingredion (NYSE:INGR) reported its Q2 CY2026 results, surpassing Wall Street's revenue expectations with $1.85 billion, though sales remained flat year-on-year. The company's non-GAAP profit of $2.82 per share also beat analyst estimates, but management lowered its full-year Adjusted EPS guidance to $10.60. Despite beating revenue estimates, the company's operating margin decreased, and free cash flow dropped significantly compared to the previous year.
Tate & Lyle Shareholders Approve Ingredion’s 595p All-Cash Offer
Ingredion (NYSE: INGR) announced its second-quarter 2026 financial results, reporting a 1% increase in net sales to $1.85 billion but a 31% decrease in reported operating income. The company reaffirmed its full-year 2026 guidance for EPS and net sales, while also confirming that Tate & Lyle shareholders have accepted its 595 pence all-cash acquisition offer, moving the deal closer to completion.
Earnings Flash (INGR) Ingredion Incorporated Reports Q2 Revenue $1.85B, vs. FactSet Est of $1.83B
Ingredion Incorporated (INGR) reported its Q2 revenue at $1.85 billion, surpassing FactSet's estimate of $1.83 billion. This financial update indicates a better-than-expected top-line performance for the company during the second quarter. The article also briefly mentions Ingredion's adjusted EPS and its expectation for the full year.
Ingredion (INGR) To Report Earnings Tomorrow: Here Is What To Expect
Ingredion (NYSE:INGR) is set to report earnings this Tuesday before market open. Analysts expect the company's revenue to be flat year-on-year, improving from a previous 2.4% decrease. The article notes that while Ingredion's stock price has been unchanged recently, its peers Darling Ingredients and Bunge Global have shown mixed results, with Darling Ingredients up and Bunge Global down after their Q2 reports.
Ingredion Incorporated $INGR Shares Sold by Alpine Woods Capital Investors LLC
Alpine Woods Capital Investors LLC significantly reduced its stake in Ingredion Incorporated by 75.4% in the first quarter, selling 43,280 shares and holding 14,129 shares valued at $1.59 million. Other institutional investors made smaller adjustments to their holdings. The article also covers recent analyst ratings, Ingredion's financial performance, and its latest dividend announcement.
Access Investment Management LLC Purchases New Holdings in Ingredion Incorporated $INGR
Access Investment Management LLC recently acquired a new position in Ingredion Incorporated, purchasing 18,165 shares valued at approximately $2.046 million. Other institutional investors have also adjusted their holdings in Ingredion, which currently has a "Hold" consensus rating from analysts with an average target price of $122.43. Ingredion reported mixed quarterly earnings, missing EPS estimates but meeting revenue expectations, and announced a quarterly dividend.
Scott Black's Top Q2 2026 Move: Exiting Ingredion Inc at a -1.4% Portfolio Impact
Scott Black, founder of Delphi Management, made significant portfolio adjustments in Q2 2026, including completely liquidating his position in Ingredion Inc, which had a -1.4% impact on his portfolio. He also added 7 new stocks, notably Affiliated Managers Group Inc and Hewlett Packard Enterprise Co, and increased stakes in 43 stocks, including Jones Lang LaSalle Inc. These moves reflect his value investing strategy of identifying undervalued opportunities and reallocating capital.
Ingredion’s acquisition of Tate & Lyle moves forward
Shareholders of Tate & Lyle PLC have approved Ingredion Inc.'s recommended cash acquisition of the London-based company for approximately $3.71 billion. This marks an important step toward creating a global leader in ingredient solutions, with the combined company projected to have nearly $10 billion in annual sales. The transaction is still subject to regulatory review and is expected to be completed in the second half of 2027.
Tate & Lyle shareholders approve acquisition by Ingredion
Shareholders of Tate & Lyle PLC have approved the recommended cash acquisition by Ingredion, Inc., with nearly 99% of votes in favor. The acquisition, valued at approximately $3.71 billion, is expected to create a global leader in ingredient solutions with annual sales of nearly $10 billion. Regulatory review is ongoing, and the transaction is anticipated to be completed in the second half of 2027.
